Arbutus Biopharma Corp

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.24

-0.13 (-2.97%)

As of Mar 22, 10:16 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 8 89%

Hold 1 11%

Sell 0 0%

Price Target

Analyst Price Target +1,108.7% upside

Low Target $34.47

Average Target $51.25

High Target $59.24

Current Price $4.24

Current
$4.24

Target
$51.25

$34.47 $51.25 avg $59.24

Scenario Analysis

Bear Case

$34.47

713.0%

Low target

Base Case

$51.25

+1,108.7%

Avg target

Bull Case

$59.24

+1,297.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$5.10

-16.9% from high

52-Week Low

$2.71

+56.7% from low

Target vs 52W High

$51.25

+904.9% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	39	69%	$257.58	+24.3%
AMGN Amgen Inc	Hold	42	50%	$190.87	-46.1%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+162.3%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	-3.7%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-89.8%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	78%	$102.31	-68.9%
INSM Insmed Inc	Strong Buy	26	92%	$143.40	-3.3%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-27.6%